Replimune Group, Inc. Share Price
NASDAQ: REPLHealthcare
Live Replimune Group, Inc. Share Price Chart
O H L
Replimune Group, Inc. Performance Overview
Days Range
▼
$12.68Low
$12.94High
Markets Today
| Previous Close | $12.87 |
|---|---|
| Open | $12.93 |
| Volume | 245,525 |
| Day's Range | $12.68 - $12.94 |
| 52W Range | $1.50 - $16.33 |
| Market Cap | $1.22 B |
Historical Performance
| 1M Returns | -17.39 |
|---|---|
| 3M Returns | +26.30 |
| 6M Returns | +90.38 |
| 1Y Returns | +271.97 |
| 5Y Returns | -60.50 |
| 10Y Returns | NA |
Replimune Group, Inc. Fundamentals
| Market Cap | $1.22 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -1.08 |
| EPS TTM | $-3.16 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 10.30 |
| EBITDA | $-316.59 M |
| Profit Margin | N/A |
| Market Cap | $1.22 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -1.08 |
| EPS TTM | $-3.16 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 10.30 |
| EBITDA | $-316.59 M |
| Profit Margin | N/A |
Replimune Group, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$79.33 M | -$90.42 M | -$84.29 M | -$71.87 M | -$73.34 M | -$68.25 M |
| EBITDA | -$78.48 M | -$89.55 M | -$85.16 M | -$69.31 M | -$72.57 M | -$67.31 M |
| Interest Expense | -$1.99 M | -$2.00 M | -$2.01 M | -$1.98 M | -$2.88 M | -$3.09 M |
| Depreciation | $848.00 K | $873.00 K | -$873.00 K | $2.56 M | $769.00 K | $937.00 K |
| Income Before Tax | -$74.24 M | -$86.69 M | -$83.10 M | -$71.24 M | -$73.46 M | -$69.77 M |
| Income Tax Expense | -$107.00 K | $0 | $0 | -$311.00 K | -$240.00 K | $0 |
| Net Income + | -$74.13 M | -$86.69 M | -$83.10 M | -$70.93 M | -$73.22 M | -$69.77 M |
| Net Profit Margin | - | - | - | - | - | - |
Replimune Group, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $77.00 K | $78.00 K | $78.00 K | $79.00 K | $82.00 K | $84.00 K |
| Reserve & Surplus | -$943.13 M | -$1.03 B | -$1.11 B | -$1.18 B | -$1.26 B | -$1.33 B |
| Non-Current Liabilities | $73.12 M | $73.23 M | $73.21 M | $72.96 M | $108.00 M | $108.39 M |
| Current Liabilities | $62.36 M | $59.56 M | $52.90 M | $50.09 M | $58.23 M | $38.41 M |
| Total Liabilities | $135.49 M | $132.79 M | $126.11 M | $123.05 M | $166.23 M | $146.80 M |
| Fixed Assets | $13.74 M | $14.68 M | $14.71 M | $13.85 M | $12.97 M | $11.86 M |
| Current Assets | $495.88 M | $413.37 M | $333.75 M | $280.35 M | $279.12 M | $200.81 M |
| Total Assets | $551.33 M | $469.51 M | $389.45 M | $333.59 M | $332.39 M | $252.45 M |
Replimune Group, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$74.13 M | -$86.69 M | -$83.10 M | -$70.93 M | -$73.22 M | -$69.77 M |
| Operating Cash Flow | -$53.73 M | -$77.02 M | -$81.21 M | -$65.95 M | -$56.16 M | -$75.73 M |
| Investing Cash Flow | -$7.70 M | $65.05 M | $84.17 M | $75.12 M | $86.51 M | $49.99 M |
| Financing Cash Flow | -$132.00 K | -$158.00 K | $324.00 K | $10.45 M | $55.68 M | $800.00 K |
| Change in Cash | -$61.12 M | -$13.74 M | $4.92 M | $20.65 M | $86.07 M | -$23.66 M |
Replimune Group, Inc. Return Calculator
The Replimune Group, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$3,972
Invested Amount$10,000
Est. Returns$-6,028
About Replimune Group, Inc.
Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies. Its proprietary oncolytic immunotherapy product candidates are designed and intended to maximally activate the immune system against cancer. Oncolytic immunotherapy is an emerging drug class. The proprietary RPx platform is based on a novel, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added that are intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. It operates in single segment of developing oncolytic immunotherapies for the treatment of cancer.
Popular Stocks
FAQs
What is the share price of Replimune Group, Inc. today?
Replimune Group, Inc. (REPL) share price as of September 18, 2026 is $12.94. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Replimune Group, Inc.?
Yes, Indian Investors can invest in the Replimune Group, Inc. (REPL) Share by opening an international trading account with Angel One.
How can I purchase Replimune Group, Inc. shares in India?
Purchasing Replimune Group, Inc. (REPL) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Replimune Group, Inc. (REPL) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Replimune Group, Inc.?
Yes, you can purchase fractional shares of Replimune Group, Inc. (REPL) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Replimune Group, Inc.?
The market capitalization of Replimune Group, Inc. on September 18, 2026, is $1.22 B.
In which sector Replimune Group, Inc. belongs?
Replimune Group, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Replimune Group, Inc. stocks?
In order to invest in Replimune Group, Inc. (REPL) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
